Hims & Hers are available in all 50 states, though not every treatment option is available in every state
The pilot program spans 18 months, from July 1, 2026, to December 31, 2027
Prevents the formation of new pigmentation
For researchers modeling systemic TB-500 uptake, repeated CNS-targeted peptide supply, or direct comparisons of intranasal versus injectable use routes, PrymaLabs nasal spray format provides a precisely characterized, research-grade starting material
Our wholesale supply model is designed to support: Bulk laboratory purchasing requirements Ongoing research inventory management Consistent product availability Secure domestic fulfillment Reliable customer support Efficient wholesale order processing Recent market developments continue to generate interest in the future of Retatrutide research